The National Times - Struggling Nissan forecasts $4.2 bn full-year net loss

Struggling Nissan forecasts $4.2 bn full-year net loss


Struggling Nissan forecasts $4.2 bn full-year net loss
Struggling Nissan forecasts $4.2 bn full-year net loss / Photo: © AFP

Japanese automaker Nissan said on Thursday it expected to suffer a net loss of 650 billion yen ($4.2 billion) in its fiscal year that ends in March, as it struggles with sluggish sales.

Change text size:

The huge loss is twice as much as analysts surveyed by Bloomberg had predicted.

The company, however, sharply lowered the forecast for its annual operating loss to 60 billion yen, citing the acceleration of its restructuring measures.

That is far less than the operating loss of 275 billion yen it had predicted at the end of October.

It is still projecting a 5.8 percent decline in revenue for the year, to 11.9 trillion yen.

The group is facing intense pressure on its sales and has had to contend with a massive hike in US tariffs.

Nissan has also faced numerous other speed bumps in recent years, including the 2018 arrest of former boss Carlos Ghosn, who later fled Japan concealed in an audio equipment box.

A merger with Japanese rival Honda had been seen as a potential lifeline, but talks collapsed last year when the company proposed making Nissan a subsidiary.

Of Japan's major automakers, Nissan was seen by analysts as likely to be the most severely hit by US President Donald Trump's tariffs.

Trade officials reached a deal in July that saw the United States lower tariffs on Japanese goods to 15 percent from a threatened 25 percent.

Japanese cars were taxed at an even higher rate of 27.5 percent and the reduction to 15 percent did not take effect until mid-September.

Nissan intends to reduce the number of its vehicle production plants from 17 to 10 by March 2028, and is targeting 20,000 job cuts worldwide by that date.

On Thursday it reported "steady progress through outsourcing, efficient use of marketing funds, leveraging shared services and expense management" and said its "workforce resizing initiatives (were) advancing responsibly".

Despite this the group said sales results in the third quarter, between October and December, were "challenging in a difficult market environment".

Revenue fell five percent year-on-year to 2.999 trillion yen, and it posted another net loss of 28.3 billion yen, though that was less severe than expected.

Nissan saw sales in the US drop another 3.7 percent year-on-year in the third quarter, although in China they were up by 12.7 percent thanks to new electric vehicle models.

L.Johnson--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: